Pharmacyclics, Inc.
(NASDAQ:PCYC)|
0.98 -0.01 (-1.01%) 2:22ET Delayed |
|
|
|
- Compare PCYC with:
- View: Line | Candlestick
Company Profile
Pharmacyclics, Inc.
995 East Arques Avenue
Sunnyvale, CA 94085-4521
United States - Map
Phone: (408) 774-0330
Fax: (408) 774-0340
Website: www.pcyc.com
State of incorporation: Delaware
CEO: Robert W. Duggan
Employees: 47
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Dev patented pharmaceutical products
A pharmaceutical company leveraging its small-molecule drug development expertise to build a pipeline in oncology and immune mediated diseases based on novel targets, pathways, and mechanisms.
Recent news for PCYC
-
PHARMACYCLICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online - Nov 26 at 6:01 ET
-
Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
PR Newswire - Nov 25 at 8:00 ET
-
EDGAR Online - Nov 13 at 1:02 ET
-
Motley Fool - Nov 06 at 12:28 ET
-
EDGAR Online Financials - Nov 05 at 9:04 ET
-
PHARMACYCLICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Oct 31 at 5:02 ET
-
EDGAR Online - Oct 30 at 1:31 ET
-
Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
PR Newswire - Oct 30 at 6:30 ET
-
PHARMACYCLICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
EDGAR Online - Oct 16 at 1:55 ET
-
Pharmacyclics upgraded by BWS Financial
Briefing.com - Oct 13 at 8:17 ET